Synbiotics and Growth

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

311 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-06-30

Study Completion Date

2009-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of the trial is to assess the growth of the infants enrolled into the study. Other parameters to be measured include microbiota balance and certain blood biochemical values. In addition the infants' digestive tolerance of the formulae and frequency of morbidity will be investigated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Symbiotic & Colonization

NCT01983072

Healthy

COMPLETED PHASE2

Evaluating the Impact of Synbiotic Supplementation on Infants and Toddlers

NCT06746285

Gastrointestinal Tolerance of Probiotics in Infants

ACTIVE_NOT_RECRUITING NA

Growth, Safety and Efficacy of a Probiotic Supplement

NCT04765852

Probiotic Supplement

COMPLETED NA

Infant Microbiota and Probiotic Intake Study

NCT02457338

Healthy

ACTIVE_NOT_RECRUITING NA

Safety Evaluation of Lactobacillus Salivarius AP-32 and Bifidobacterium Animalis Subsp. Lactis CP-9 in Healthy Infants.

NCT04140604

Safety Issues

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The infants will be recruited between birth and 14 days of life and will start on the allocated study formula as soon as they are enrolled. In practice this will tend to be immediately after birth. The treatment period, in terms of data necessary for the primary outcome, will be until they reach 16 weeks old. Growth and other measurements will be collected on five separate occasions during this period, ie 2, 4, 8, 12 and 16 weeks of life. Although the study intervention formally ends at 16 weeks, it will be useful to have a follow up visit at 26 weeks to collect further data on the gut microflora in the sub-group of infants who have already provided a stool sample at 8 weeks. This follow-up visit will be of benefit to the subject as they receive a weight check and clinical examination by a paediatrician and will be offered to all subjects (no invasive procedures will be carried out).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infants Growth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard starter infant formula

starter infant formula from enrollment till 16 weeks of age

Group Type PLACEBO_COMPARATOR

Infant formula

Intervention Type OTHER

infant formula

starter infant formula with prebiotics

starter infant formula from enrollment till 16 weeks of age

Group Type EXPERIMENTAL

Infant formula

Intervention Type OTHER

infant formula

starter infant formula with pro and prebiotics

starter infant formula from enrollment till 16 weeks of age

Group Type EXPERIMENTAL

Infant formula

Intervention Type OTHER

infant formula

breastfeeding group

exclusively breastfeeding during the first 16 weeks of age

Group Type OTHER

Breastfeeding

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Infant formula

infant formula

Intervention Type OTHER

Breastfeeding

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy new-born infant
* Infant is less14 days old on day of enrollment
* Birthweight between 2500g and 4500g
* Gestational age over 37 weeks
* Singleton birth
* Infant's mother, before the 14th day of the child's life, has elected not to breastfeed
* Infant randomized in to a treatment group can expected to be exclusively fed the formula from enrolment until 16 weeks old
* Having obtained his/her legal representative's informed consent

Exclusion Criteria

* Currently participating in another clinical trial
* Congenital illness or malformation that may affect normal growth
* Significant pre-natal and/or post-natal disease
* Re-hospitalisation for more than 2 days in the first 14 days of life. (Exceptionally, infants re-hospitalized because of jaundice may be enrolled in the study).
* Receiving antibiotic treatment at time of enrolment or in the 5 previous days.
* Receiving infant formula containing probiotics and/or prebiotics at the time of enrolment

Maximum Eligible Age

14 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes